Mycobacterium bovis bacillus Calmette-Guérin (BCG), a live attenuated vaccine derived from a virulent strain of M. bovis against tuberculosis (TB), has a protective efficacy of 60–80% against severe forms of tuberculosis in children, particularly tuberculous meningitis or miliary tuberculosis